Who has invested in Keros Therapeutics?

Foresite Capital, OrbiMed, Cowen Healthcare Investments, Venrock, Pontifax, Arkin Bio Ventures are named among the investors backing Keros Therapeutics.

Keros Therapeutics Funding: $79M Raised, Series C (2020)

Keros Therapeutics funding overview

Keros Therapeutics is based in Lexington. Keros Therapeutics has raised $79M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in March 2020. The round record for Keros Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Foresite Capital, OrbiMed, Cowen Healthcare Investments, Venrock, Pontifax, Arkin Bio Ventures and 3 others. 9 distinct backers are named across the disclosed rounds.

Keros Therapeutics at a glance

Total raised: $79M
Latest round: Series C
Latest round date: March 2020
Headquarters: Lexington
Notable investors: Foresite Capital, OrbiMed, Cowen Healthcare Investments, Venrock, Pontifax, Arkin Bio Ventures, Partners Innovation Fund, Global Health Sciences Fund

Frequently asked about Keros Therapeutics funding

How much has Keros Therapeutics raised?: Keros Therapeutics has raised $79M in total disclosed funding across the rounds on record.
Who has invested in Keros Therapeutics?: Foresite Capital, OrbiMed, Cowen Healthcare Investments, Venrock, Pontifax, Arkin Bio Ventures are named among the investors backing Keros Therapeutics.
What was the latest Keros Therapeutics funding round?: The most recent disclosed round is a Series C, announced in March 2020.
Where is Keros Therapeutics based?: Keros Therapeutics is based in Lexington.
When did Keros Therapeutics last raise?: The last disclosed Keros Therapeutics round closed in March 2020 at Series C.

Keros Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Lexington below to benchmark round size and investor mix.

Keros Therapeutics Funding: $79M Raised, Series C (2020)

Keros Therapeutics funding overview

Keros Therapeutics at a glance

Frequently asked about Keros Therapeutics funding

Companies related to Keros Therapeutics (30)

Browse related funding lists (7)